These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33625351)

  • 61. Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study.
    Bulabula ANH; Nelson JA; Musafiri EM; Machekano R; Sam-Agudu NA; Diacon AH; Shah M; Creswell J; Theron G; Warren RM; Jacobson KR; Chirambiza JP; Kalumuna D; Bisimwa BC; Katoto PDMC; Kaswa MK; Birembano FM; Kitete L; Grobusch MP; Kashongwe ZM; Nachega JB
    Clin Infect Dis; 2019 Sep; 69(8):1278-1287. PubMed ID: 30759187
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diagnostic value of Xpert MTB/RIF Ultra for osteoarticular tuberculosis.
    Sun Q; Wang S; Dong W; Jiang G; Huo F; Ma Y; Huang H; Wang G
    J Infect; 2019 Aug; 79(2):153-158. PubMed ID: 31207324
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of the tuberculosis culture color plate test for rapid detection of drug susceptible and drug-resistant Mycobacterium tuberculosis in a resource-limited setting, Addis Ababa, Ethiopia.
    Mekonnen B; Mihret A; Getahun M; Hailu T; Sidiki S; V Kelley H; Scordo JM; Hunt WG; Pan X; Balada-Llasat JM; Gebreyes W; Evans CA; Aseffa A; Torrelles JB; Wang SH; Abebe T
    PLoS One; 2019; 14(5):e0215679. PubMed ID: 31136575
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis.
    Elbrolosy AM; El Helbawy RH; Mansour OM; Latif RA
    BMC Microbiol; 2021 May; 21(1):144. PubMed ID: 33980173
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea.
    Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T
    Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of the Xpert MTB/RIF assay for diagnosis of tuberculosis and rifampin resistance in county-level laboratories in Hunan province, China.
    Hu P; Bai L; Liu F; Ou X; Zhang Z; Yi S; Chen Z; Gong D; Liu B; Guo J; Tan Y
    Chin Med J (Engl); 2014; 127(21):3744-50. PubMed ID: 25382330
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Direct drug susceptibility testing of Mycobacterium tuberculosis using the proportional method: A multicenter study.
    Amini S; Hoffner S; Allahyar Torkaman MR; Hamzehloo G; Nasiri MJ; Salehi M; Sami Kashkooli G; Shahraki MS; Mohsenpoor M; Soleimanpour S; Mir R
    J Glob Antimicrob Resist; 2019 Jun; 17():242-244. PubMed ID: 30630107
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rapid detection of rifampicin susceptibility of Mycobacterium tuberculosis in sputum specimens by mycobacteriophage assay.
    Butt T; Ahmad RN; Afzal RK; Mahmood A; Anwar M
    J Pak Med Assoc; 2004 Jul; 54(7):379-82. PubMed ID: 15449922
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.
    Rice JP; Seifert M; Moser KS; Rodwell TC
    PLoS One; 2017; 12(10):e0186139. PubMed ID: 29016684
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
    Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
    Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid.
    Shah M; Paradis S; Betz J; Beylis N; Bharadwaj R; Caceres T; Gotuzzo E; Joloba M; Mave V; Nakiyingi L; Nicol MP; Pradhan N; King B; Armstrong D; Knecht D; Maus CE; Cooper CK; Dorman SE; Manabe YC
    Clin Infect Dis; 2020 Aug; 71(5):1161-1167. PubMed ID: 31560049
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
    Tam KK; Leung KS; To SW; Siu GK; Lau TC; Shek VC; Tse CW; Wong SS; Ho PL; Yam WC
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):118-124. PubMed ID: 28780247
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Diagnostic efficiency of Xpert MTB/RIF assay for osteoarticular tuberculosis in patients with inflammatory arthritis in China.
    Li Y; Jia W; Lei G; Zhao D; Wang G; Qin S
    PLoS One; 2018; 13(6):e0198600. PubMed ID: 29856840
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rifampicin resistance patterns and dynamics of tuberculosis and drug-resistant tuberculosis in Enugu, South Eastern Nigeria.
    Ugwu KO; Onah IS; Mbah GC; Ezeonu IM
    J Infect Dev Ctries; 2020 Sep; 14(9):1011-1018. PubMed ID: 33031090
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Direct Detection of Rifampin and Isoniazid Resistance in Sputum Samples from Tuberculosis Patients by High-Resolution Melt Curve Analysis.
    Anthwal D; Gupta RK; Bhalla M; Bhatnagar S; Tyagi JS; Haldar S
    J Clin Microbiol; 2017 Jun; 55(6):1755-1766. PubMed ID: 28330890
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Performance Assessment of Xpert MTB/RIF Assay for Detecting Pulmonary Tuberculosis and Rifampin Resistance in a Tertiary Care Hospital in Korea.
    Chang J; Sung H; Jo KW; Shim TS; Kim MN
    Jpn J Infect Dis; 2021 Nov; 74(6):537-542. PubMed ID: 33790071
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Xpert® MTB/RIF assay evaluation in South Korea, a country with an intermediate tuberculosis burden.
    Kim SY; Kim H; Kim SY; Ra EK; Joo SI; Shin S; Seong MW; Yoo CG; Kim EC; Park SS
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1471-6. PubMed ID: 22981162
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Direct Susceptibility Testing on MGIT 960 TB System: A Rapid Method for Detection of Drug Resistant Tuberculosis.
    Tayyab N; Zaman G; Satti L; Ikram A; Gardezi AH; Khadim MT
    J Coll Physicians Surg Pak; 2018 Aug; 28(8):590-593. PubMed ID: 30060785
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Xpert MTB/RIF Ultra improved the diagnosis of paucibacillary tuberculosis: A prospective cohort study.
    Wang G; Wang S; Jiang G; Yang X; Huang M; Huo F; Ma Y; Dai G; Li W; Chen X; Huang H
    J Infect; 2019 Apr; 78(4):311-316. PubMed ID: 30796951
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diagnostic Efficacy, Sensitivity, and Specificity of Xpert MTB/RIF Assay for Spinal Tuberculosis and Rifampicin Resistance.
    Patel J; Upadhyay M; Kundnani V; Merchant Z; Jain S; Kire N
    Spine (Phila Pa 1976); 2020 Feb; 45(3):163-169. PubMed ID: 31513101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.